Consolidated Statements of Income - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Revenue
Total revenue	$ 519,907,752	$ 356,355,930
Operating Expenses
Cost of services	361,132,111	273,453,287
General and administrative expenses	43,353,787	26,249,532
Depreciation and amortization	19,303,179	19,075,353
Provision for doubtful accounts	3,887,647	0
Impairment of goodwill and intangibles	3,798,866	2,431,791
Total expenses	431,475,590	321,209,963
Income from operations	88,432,162	35,145,967
Other (expense) income
Loss from equity method investments	(8,125,285)	(1,112,541)
Interest expense	(560,515)	(79,689)
Interest income	1,258,638	1,015,204
Change in fair value of derivative instrument	0	(44,886)
Gain on settlement of preexisting note receivable from ApolloMed	0	921,938
Gain from investments– fair value adjustments	0	13,697,018
Other income	1,622,131	168,102
Total other (expense) income, net	(5,805,031)	14,565,146
Income before provision for income taxes	82,627,131	49,711,113
Provision for income taxes	22,359,640	3,886,785
Net income	60,267,491	45,824,328
Net income attributable to noncontrolling interests	49,432,489	20,022,486
Net income attributable to Apollo Medical Holdings, Inc.	$ 10,835,002	$ 25,801,842
Earnings per share – basic	$ 0.33	$ 1.01
Earnings per share – diluted	$ 0.29	$ 0.90
Weighted average shares of common stock outstanding – basic	32,893,940	25,525,786
Weighted average shares of common stock outstanding – diluted	37,914,886	28,661,735
Capitation, net [Member]
Revenue
Total revenue	$ 344,307,058	$ 272,921,240
Health Care, Other [Member]
Revenue
Total revenue	100,927,841	44,598,373
Management Service [Member]
Revenue
Total revenue	49,742,755	26,983,695
Health Care, Patient Service [Member]
Revenue
Total revenue	19,703,999	7,449,249
Product and Service, Other [Member]
Revenue
Total revenue	$ 5,226,099	$ 4,403,373